CLO26-113: Real-World ESR1 Gene Mutation Testing Appropriateness and Prescribing Patterns for ER-Positive HER2-Negative Advanced or Metastatic Breast Cancer [0.03%]
真实世界中ER阳性HER2阴性晚期或转移性乳腺癌的ESR1基因突变检测适宜性和处方模式
Michael Leone,Annette Hood,Katie Konieczny et al.
Michael Leone et al.
EPR26-152: GLP-1 and Dual Agonists and the Incidence of Skin Cancer: Evidence from Randomized Controlled Trials [0.03%]
EPR26-152：GLP-1和双受体激动剂与皮肤癌发病率：随机对照试验的证据
Yu-Cheng Chang,Yuliya Prystupa,Chun-Chiao Yu et al.
Yu-Cheng Chang et al.
HSR26-240: Patient-Reported Outcomes, Race and Ethnicity in Gastric Cancer Clinical Trials [0.03%]
胃癌临床试验中的患者报告结果、种族和族裔差异(HSR26-240)
Chandra L Kakarala,Mahnoor Sukaina,Yagnapriya Ammakola et al.
Chandra L Kakarala et al.
CGE26-135: Differential Germline Mutation Spectrum Analysis in Familial and Inherited Breast Cancer Patients in Pakistan [0.03%]
巴基斯坦家族性乳腺癌患者中不同的生殖系突变类型分析研究
Neha Ashfaq,Abdul Waheed,Omema Saleem et al.
Neha Ashfaq et al.
QIM26-305: Central Fill Optimization to Reduce Drug Waste and Enhance Multidisciplinary Workflow Within an Ambulatory Infusion Suite [0.03%]
QIM26-305：门诊输液室中心填充优化以减少药物浪费和增强多学科工作流程
Lisa Fidyk,Lisa J George,Bradley Pyle et al.
Lisa Fidyk et al.
BPI26-031: Comparative Diagnostic and Prognostic Value of FES PET/CT Versus FDG PET/CT in ER-Positive Breast Cancer: An Umbrella Review [0.03%]
BPI26-031：FES-PET/CT与FDG-PET/CT在ER阳性乳腺癌诊断和预后中的比较价值：伞式综述
Nain Tara,Hina Zubair,Sheeza Nawaz et al.
Nain Tara et al.
EPR26-172: Early Inpatient Chemotherapy in Lung Cancer: Predictors, Treatment Patterns, and Superior In-Hospital Outcomes Despite Higher Tumor Burden [0.03%]
肺癌早期住院化疗：预测因子、治疗模式及住院结局更优但肿瘤负荷更大(EPR26-172)
Meher Ayyaz Uddin,Fiqe Khan
Meher Ayyaz Uddin
BPI26-030: Real-World Adherence to NCCN-Guideline-Recommended Peri-Operative Systemic Therapy in Muscle-Invasive Urothelial Carcinoma: An NCDB Analysis (2018-2021) [0.03%]
26-030：2018至2021年美国国家癌症数据库（NCDB）中肌层浸润性尿路上皮癌围手术期系统治疗的现实世界依从性分析（NCCN指南推荐）
Zin W Myint,Nicole A Lisek,Jackson C Horn et al.
Zin W Myint et al.
QIM26-279: Increasing Equitable Adherence to Annual Lung Cancer Screenings and Diagnostic Surveillance: A Pragmatic Factorial Trial [0.03%]
增加年度肺癌筛查和诊断监测的公平依从性：一项实用因子试验
Sana Zeb,Jennifer Steltz,Chelsea Saia et al.
Sana Zeb et al.
PCO26-273: Development and Evaluation of a Crosslinked β-cyclodextrin Nanocarrier for Codelivery of Doxorubicin and Pexidartinib in Colorectal Cancer Therapy [0.03%]
PCO26-273：开发和评估用于结直肠癌治疗的交联β-环糊精纳米载体联合递送多西他赛和佩西达汀ibs的研究与发展评估
Alaa Aboushanab,Jingjing Sun
Alaa Aboushanab